Showing 1,268 results

Filters Content type: News, Editors' picks Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

Pharmaceutical industry

Mylan Introduces Symfi™ Triple Combo Once-Daily HIV Treatment in the U.S.

Editor's pick
Mylan press release
3 April 2018
New & experimental HIV treatments

Ibalizumab-uiyk for HIV: What Pharmacists Should Know

Editor's pick
Pharmacy Times
27 March 2018
New & experimental HIV treatments

ViiV Healthcare gains CHMP Positive Opinion for Juluca (dolutegravir/rilpivirine) in Europe

Editor's pick
ViiV press release
23 March 2018
New & experimental HIV treatments

Powerful new PrEP and treatment drug should be effective as a small weekly pill

News
12 March 2018
New & experimental HIV treatments

Ibalizumab, active against highly resistant HIV, now approved in US

News
8 March 2018
People with limited treatment options

FDA approves new HIV treatment for patients who have limited treatment options

Editor's pick
FDA
7 March 2018
Changing treatment

Biktarvy combo maintains viral suppression after switching therapy

News
7 March 2018
The search for a cure

Experimental antibody plus TLR7 agonist maintains viral suppression in monkeys

News
5 March 2018
New & experimental HIV treatments

CytoDyn Reports Primary Endpoint Achieved in PRO 140 Pivotal Combination Therapy Trial in HIV Infection

Editor's pick
CytoDyn press release
21 February 2018
New & experimental HIV treatments

Mylan (MYL) Announces Tentative Approval for Combination HIV Treatment DTG/FTC/TAF Under FDA's PEPFAR Program

Editor's pick
Mylan press release
20 February 2018
New & experimental HIV treatments

US regulators approve new HIV combo pill containing bictegravir

News
8 February 2018
New & experimental HIV treatments

ViiV Healthcare launches eighth phase III study in two-drug regimen programme for HIV-1 treatment

Editor's pick
ViiV press release
8 February 2018
New & experimental HIV treatments

US FDA approves Gilead triple HIV drug, rival files lawsuit

Editor's pick
Reuters
8 February 2018
Injectable & long-acting PrEP

Long-acting injectable ARVs are convenient and private, study participants report

News
17 January 2018
Pharmaceutical industry

Teva Announces Exclusive Launch of a Generic Version of Reyataz® in the United States

Editor's pick
Teva press release
10 January 2018
Injectable & long-acting HIV treatment

New 'mini-pillbox' device could deliver three HIV drugs in a single once-weekly dose

News
9 January 2018
New & experimental HIV treatments

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

Editor's pick
Yale News
8 January 2018
New & experimental HIV treatments

FDA Accepts New Drug Applications for Merck’s Doravirine, the Company’s Investigational Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), for Treatment of HIV-1 Infection

Editor's pick
Merck press release
8 January 2018
New & experimental HIV treatments

HIV Drugs in the Pipeline: Expected Approvals for 2018

Editor's pick
Infectious Disease Special Edition
31 December 2017
New & experimental HIV treatments

Dolutegravir and lamivudine potent and safe in people starting HIV therapy for the first time

News
28 December 2017
Treatment simplification strategies

Could we safely reduce the frequency of treatments for HIV-positive people?

Editor's pick
The Conversation
8 December 2017
New & experimental HIV treatments

FDA Approves Juluca, the First Two-Drug HIV Regimen

Editor's pick
Poz
22 November 2017
HIV treatment

Top 10 HIV Clinical Developments of 2017

Editor's pick
The Body Pro
19 November 2017
The search for a cure

European Cure Review concentrates on HIV therapeutic vaccines

News
16 November 2017